CG Oncology's stock has dropped 40% since its IPO peak, driven by profit-taking and competitive concerns despite promising ...

With the purchase of Gemzar ® from Eli Lilly and Company, which was signed on 2 October 2024 and closed on 13 December 2024, the CHEPLAPHARM Group is once again expanding its existing portfolio in the ...

With the purchase of Gemzar ® from Eli Lilly and Company, which was signed on 2 October 2024 and closed on 13 December 2024, the CHEPLAPHARM Group is once again expanding its existing portfolio ...

16.12.2024 / 08:48 CET/CEST The issuer is solely responsible for the content of this announcement. CHEPLAPHARM ACQUIRES GEMZAR ® FROM LILLY Binningen/Greifswald, 16 December 2024 With the ...